Literature DB >> 3714614

Interaction between carbamazepine and dextropropoxyphene.

Y L Yu, C Y Huang, D Chin, E Woo, C M Chang.   

Abstract

Serious side effects may result from the concurrent administration of the usual dosage of carbamazepine and dextropropoxyphene. Three cases are reported and the mechanisms and implications discussed.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3714614      PMCID： PMC2418624          DOI： 10.1136/pgmj.62.725.231

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

1.  Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection.

Authors:  E Gold
Journal:  N Engl J Med       Date:  1966-01-27       Impact factor: 91.245

2.  Distribution and elimination kinetics of carbamazepine in man.

Authors:  M D Rawlins; P Collste; L Bertilsson; L Palmér
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of carbamazepine.

Authors:  L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

4.  Interaction between carbamazepine and propoxyphene in man.

Authors:  M Dam; C B Kristensen; B S Hansen; J Christiansen
Journal:  Acta Neurol Scand       Date:  1977-12       Impact factor: 3.209

5.  Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man.

Authors:  B S Hansen; M Dam; J Brandt; E F Hvidberg; H Angelo; J M Christensen; P Lous
Journal:  Acta Neurol Scand       Date:  1980-06       Impact factor: 3.209
  5 in total
  5 in total

1.  Cerebellar dysfunction following dextropropoxyphene-induced carbamazepine toxicity.

Authors:  S Allen
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

Review 2.  Drug interactions of clinical significance with opioid analgesics.

Authors:  P M Maurer; R R Bartkowski
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

3.  [Sustained-release dextropropoxyphene.].

Authors:  K Kurz-Müller; M Zenz
Journal:  Schmerz       Date:  1991-12       Impact factor: 1.107

Review 4.  Antiepileptic drugs. A review of clinically significant drug interactions.

Authors:  P N Patsalos; J S Duncan
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

Review 5.  Clinically significant drug-drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review.

Authors:  Aleksandra Kotlinska-Lemieszek; Pål Klepstad; Dagny Faksvåg Haugen
Journal:  Drug Des Devel Ther       Date:  2015-09-16       Impact factor: 4.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.